GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (LTS:0HNZ) » Definitions » Float Percentage Of Total Shares Outstanding

Fagron (LTS:0HNZ) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fagron's float shares is 0.00 Mil. Fagron's total shares outstanding is 72.84 Mil. Fagron's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fagron's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fagron's Institutional Ownership is 38.00%.


Fagron Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Fagron's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/72.84
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fagron Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (LTS:0HNZ) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

No Headlines